Atlantic American Faces October 12 Deadline to File Delinquent Reports or Risk Delisting
AAME is trading near its 52-week low of $1.59 (2.5% above the low).
Summary
Nasdaq has given Atlantic American until October 12, 2026, to file its delayed annual and quarterly reports. Failure to do so will trigger delisting proceedings.
Key Events · Legal and Risk Events · AAME
-
Nasdaq Extension Granted
A 180-day extension from the original 10-K due date gives Atlantic American until October 12, 2026, to file its delinquent 2025 10-K and first-quarter 2026 10-Q.
-
Delisting Risk Remains
Should the company fail to file the required reports by October 12, Nasdaq will notify it that its common stock faces delisting, though an appeal is possible.
-
Ongoing Compliance Struggles
This marks the third Nasdaq-related 8-K since April 2026, following two prior notices for late filings and a CFO resignation in May, highlighting persistent financial reporting challenges.
-
Stock Near 52-Week Low
Shares trade at $1.63, just above the 52-week low of $1.59, signaling market skepticism about the company's ability to resolve its reporting delays.
Analysis · AAME · Finance
Atlantic American Corporation now has until October 12, 2026, to submit its overdue 2025 10-K and first-quarter 2026 10-Q. Missing this deadline would prompt Nasdaq to initiate delisting proceedings. The company has been under scrutiny since April, having received two Nasdaq notices and seen its CFO resign. Trading near its 52-week low, the stock reflects mounting market concern. While the extension offers temporary relief, the threat of delisting remains pressing.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AAME was trading at $1.63 on NASDAQ in the Finance sector, with a market capitalization of approximately $33.2M. The 52-week trading range was $1.59 to $3.71. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.